239 related articles for article (PubMed ID: 25784176)
61. Mesenchyme homeobox 2 has a cancer-inhibiting function in breast carcinoma via affection of the PI3K/AKT/mTOR and ERK1/2 pathways.
Cai Y; Liu Y; Sun Y; Ren Y
Biochem Biophys Res Commun; 2022 Feb; 593():20-27. PubMed ID: 35051778
[TBL] [Abstract][Full Text] [Related]
62. Combination therapy of RY10-4 with the γ-secretase inhibitor DAPT shows promise in treating HER2-amplified breast cancer.
Su F; Zhu S; Ruan J; Muftuoglu Y; Zhang L; Yuan Q
Oncotarget; 2016 Jan; 7(4):4142-54. PubMed ID: 26716652
[TBL] [Abstract][Full Text] [Related]
63. Lentivirus-mediated PLCγ1 gene short-hairpin RNA suppresses tumor growth and metastasis of human gastric adenocarcinoma.
Zhang B; Wang F; Dai L; Cai H; Zhan Y; Gang S; Hu T; Xia C; Zhang B
Oncotarget; 2016 Feb; 7(7):8043-54. PubMed ID: 26811493
[TBL] [Abstract][Full Text] [Related]
64. MicroRNA-149 is epigenetically silenced tumor-suppressive microRNA, involved in cell proliferation and downregulation of AKT1 and cyclin D1 in human glioblastoma multiforme.
Ghasemi A; Fallah S; Ansari M
Biochem Cell Biol; 2016 Dec; 94(6):569-576. PubMed ID: 27783537
[TBL] [Abstract][Full Text] [Related]
65. A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer.
Kim do Y; Park EY; Chang E; Kang HG; Koo Y; Lee EJ; Ko JY; Kong HK; Chun KH; Park JH
Oncotarget; 2016 Mar; 7(12):14791-802. PubMed ID: 26895471
[TBL] [Abstract][Full Text] [Related]
66. Wood dust exposure induces cell transformation through EGFR-mediated OGG1 inhibition.
Staffolani S; Manzella N; Strafella E; Nocchi L; Bracci M; Ciarapica V; Amati M; Rubini C; Re M; Pugnaloni A; Pasquini E; Tarchini P; Valentino M; Tomasetti M; Santarelli L
Mutagenesis; 2015 Jul; 30(4):487-97. PubMed ID: 25711499
[TBL] [Abstract][Full Text] [Related]
67. Long non-coding RNA IGF2-AS represses breast cancer tumorigenesis by epigenetically regulating IGF2.
Zhang Y; Yan H; Jiang Y; Chen T; Ma Z; Li F; Lin M; Xu Y; Zhang X; Zhang J; He H
Exp Biol Med (Maywood); 2021 Feb; 246(4):371-379. PubMed ID: 33175607
[TBL] [Abstract][Full Text] [Related]
68. Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis.
Javeri A; Ghaffarpour M; Taha MF; Houshmand M
Med Oncol; 2013 Mar; 30(1):413. PubMed ID: 23292869
[TBL] [Abstract][Full Text] [Related]
69. Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical use.
Michailidi C; Hayashi M; Datta S; Sen T; Zenner K; Oladeru O; Brait M; Izumchenko E; Baras A; VandenBussche C; Argos M; Bivalacqua TJ; Ahsan H; Hahn NM; Netto GJ; Sidransky D; Hoque MO
Cancer Prev Res (Phila); 2015 Mar; 8(3):208-21. PubMed ID: 25586904
[TBL] [Abstract][Full Text] [Related]
70. MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor gene.
Phua YW; Nguyen A; Roden DL; Elsworth B; Deng N; Nikolic I; Yang J; Mcfarland A; Russell R; Kaplan W; Cowley MJ; Nair R; Zotenko E; O'Toole S; Tan SX; James DE; Clark SJ; Kouros-Mehr H; Swarbrick A
Breast Cancer Res; 2015 Jun; 17(1):83. PubMed ID: 26070602
[TBL] [Abstract][Full Text] [Related]
71. MicroRNA-486-5p targeting PIM-1 suppresses cell proliferation in breast cancer cells.
Zhang G; Liu Z; Cui G; Wang X; Yang Z
Tumour Biol; 2014 Nov; 35(11):11137-45. PubMed ID: 25104088
[TBL] [Abstract][Full Text] [Related]
72. Combined Inhibition of DNMT and HDAC Blocks the Tumorigenicity of Cancer Stem-like Cells and Attenuates Mammary Tumor Growth.
Pathania R; Ramachandran S; Mariappan G; Thakur P; Shi H; Choi JH; Manicassamy S; Kolhe R; Prasad PD; Sharma S; Lokeshwar BL; Ganapathy V; Thangaraju M
Cancer Res; 2016 Jun; 76(11):3224-35. PubMed ID: 27197203
[TBL] [Abstract][Full Text] [Related]
73. MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.
Guo L; Wang J; Yang P; Lu Q; Zhang T; Yang Y
IUBMB Life; 2015 Sep; 67(9):720-5. PubMed ID: 26314828
[TBL] [Abstract][Full Text] [Related]
74. Resveratrol inhibits the proliferation and induces the apoptosis in ovarian cancer cells via inhibiting glycolysis and targeting AMPK/mTOR signaling pathway.
Liu Y; Tong L; Luo Y; Li X; Chen G; Wang Y
J Cell Biochem; 2018 Jul; 119(7):6162-6172. PubMed ID: 29663499
[TBL] [Abstract][Full Text] [Related]
75. Trichostatin A and Tamoxifen inhibit breast cancer cell growth by miR-204 and ERα reducing AKT/mTOR pathway.
Liu J; Li Y
Biochem Biophys Res Commun; 2015 Nov; 467(2):242-7. PubMed ID: 26436206
[TBL] [Abstract][Full Text] [Related]
76. miR-99a directly targets the mTOR signalling pathway in breast cancer side population cells.
Yang Z; Han Y; Cheng K; Zhang G; Wang X
Cell Prolif; 2014 Dec; 47(6):587-95. PubMed ID: 25348507
[TBL] [Abstract][Full Text] [Related]
77. Vanadium quercetin complex attenuates mammary cancer by regulating the P53, Akt/mTOR pathway and downregulates cellular proliferation correlated with increased apoptotic events.
Roy S; Banerjee S; Chakraborty T
Biometals; 2018 Aug; 31(4):647-671. PubMed ID: 29855745
[TBL] [Abstract][Full Text] [Related]
78. MicroRNA-let-7a regulates cell autophagy by targeting Rictor in gastric cancer cell lines MGC-803 and SGC-7901.
Fan H; Jiang M; Li B; He Y; Huang C; Luo D; Xu H; Yang L; Zhou J
Oncol Rep; 2018 Mar; 39(3):1207-1214. PubMed ID: 29328491
[TBL] [Abstract][Full Text] [Related]
79. Ampelopsin attenuates brain aging of D-gal-induced rats through miR-34a-mediated SIRT1/mTOR signal pathway.
Kou X; Liu X; Chen X; Li J; Yang X; Fan J; Yang Y; Chen N
Oncotarget; 2016 Nov; 7(46):74484-74495. PubMed ID: 27780933
[TBL] [Abstract][Full Text] [Related]
80. Growth inhibitory effect of rapamycin in Hodgkin-lymphoma cell lines characterized by constitutive NOTCH1 activation.
Nagy N; Hajdu M; Márk Á; Király PA; Tóth M; Dankó T; Csóka M; Sebestyén A
Tumour Biol; 2016 Oct; 37(10):13695-13704. PubMed ID: 27473087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
